Contact Us
800.227.0627

Bridged Nucleic Acids - BNA - TEW

 
Print Print
Please select subject area:
Bridged Nucleic Acids - BNA
Biosyn
Specific Detection of Nucleic Acids with SHIP
12/11/2024
Biosyn
Circular RNA or Cyclic RNA could be used in diagnostics, therapeutics, and biotechnology
12/04/2024
Biosyn
Bioconjugation for Nucleic Acids Drug Conjugates and Therapeutics
10/17/2024
Biosyn
Effects of Modifications on Nucleic Acid Properties
10/16/2024
Biosyn
Highly nuclease resistance and thermodynamically stable 2′-O,4′-C-Ethylene-bridged Nucleic Acid (ENA) as a promising candidate for antisense therapy
01/12/2024
Biosyn
Therapeutic tiny or short modified antisense oligonucleotides (Tiny ASOs) can block gene expression or modulate splice-switching!
11/06/2023
Biosyn
Therapeutic Antisense Oligonucleotides (ASOs) and their Modifications
10/25/2023
Biosyn
A triplex-forming bridged nucleic acid oligonucleotide peptide conjugate increases transfection efficiency by targeting the nucleus
12/20/2022
Biosyn
Phosphate modifications for gene silencing with RNAi
03/31/2021
Biosyn
5'-Phosphate modifications for gene silencing with RNAi
03/31/2021
Biosyn
Sugar modifications for gene silencing using siRNA
03/26/2021
Biosyn
Therapeutic peptide discovery via high throughput screening of random peptide phage-display library
03/24/2021
Biosyn
Limited solid tumor penetration by Herceptin antibody-based cancer drugs
03/08/2021
Biosyn
Fatty acid conjugated BNA antisense oligonucleotides exhibit enhanced uptake into muscle
03/04/2021
Biosyn
FDA approves second RNA interference-inducing siRNA oligonucleotide drug for treating acute hepatic porphyria, raising the prospect for cancer therapy
02/23/2021
1234567
imgscroll